EIKEN CHEMICAL CO.,LTD. 4549Short Interest
Estimated short interest in EIKEN CHEMICAL CO.,LTD. (4549) is 1.27% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd.
Estimated short interest
1.27%
±0.00%
Estimated position (shares)
441,533
As of 2026-11-18
Holders (0.5% or more)
1 firms
490 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 8 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-10-26 |
|---|---|
| Latest disclosure | 2026-11-12 (Barclays Capital Securities Ltd, 1.27%) |
| Reporting institutions | 11 firms (490 reports) |
| Peak estimated short interest | 4.05% (2026-08-28, 3 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- GOLDMAN SACHS INTERNATIONAL
- Citigroup Global Markets Limited
- Integrated Core Strategies (Asia) Pte. Ltd.
- Morgan Stanley MUFG Securities Co., Ltd.
- Others
1.27%
Estimated short interest, 2026-11-18
Barclays Capital Securities Ltd1.27%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-12 | Barclays Capital Securities Ltd | Position 441,533 shares | Ratio 1.27% | ▼0.04% | Holding |
| 2017-12-13 | Credit Suisse Securities (Europe) Limited | Position 108,512 shares | Ratio 0.49% | ▼0.03% | Below 0.5% |
| 2026-06-09 | MERRILL LYNCH INTERNATIONAL | Position 167,017 shares | Ratio 0.48% | ▼0.02% | Below 0.5% |
| 2026-06-12 | Daiwa Securities Co. Ltd. | Position 168,940 shares | Ratio 0.48% | ▼0.05% | Below 0.5% |
| 2026-11-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 161,494 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
| 2026-03-04 | GOLDMAN SACHS INTERNATIONAL | Position 154,354 shares | Ratio 0.44% | ▼0.14% | Below 0.5% |
| 2020-07-15 | Nomura International plc | Position 165,100 shares | Ratio 0.37% | ▼0.15% | Below 0.5% |
| 2026-08-31 | Citigroup Global Markets Limited | Position 90,323 shares | Ratio 0.26% | ▼1.68% | Below 0.5% |
| 2020-06-05 | Individual | Position 4,400 shares | Ratio 0.01% | ▼0.49% | Below 0.5% |
| 2020-06-16 | Credit Suisse AG | Position 0 shares | Ratio 0.00% | ▼0.55% | Closed |
| 2025-02-18 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 0 shares | Ratio 0.00% | ▼1.18% | Closed |
Disclosure History 490 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-12 | Barclays Capital Securities Ltd | Position 441,533 shares | Ratio 1.27% | ▼0.04% | — |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 455,533 shares | Ratio 1.31% | ▲0.02% | — |
| 2026-11-05 | Barclays Capital Securities Ltd | Position 445,633 shares | Ratio 1.29% | ▼0.08% | — |
| 2026-11-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 161,494 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
| 2026-10-22 | Morgan Stanley MUFG Securities Co., Ltd. | Position 205,262 shares | Ratio 0.59% | ▼0.06% | — |
| 2026-10-21 | Barclays Capital Securities Ltd | Position 474,633 shares | Ratio 1.37% | ▼0.04% | — |
| 2026-10-21 | Morgan Stanley MUFG Securities Co., Ltd. | Position 225,962 shares | Ratio 0.65% | ▼0.08% | — |
| 2026-10-09 | Barclays Capital Securities Ltd | Position 487,833 shares | Ratio 1.41% | ▲0.13% | — |
| 2026-10-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 255,062 shares | Ratio 0.73% | ▲0.10% | — |
| 2026-09-28 | Barclays Capital Securities Ltd | Position 442,725 shares | Ratio 1.28% | ▼0.02% | — |
| 2026-09-10 | Morgan Stanley MUFG Securities Co., Ltd. | Position 219,118 shares | Ratio 0.63% | ▼0.09% | — |
| 2026-09-07 | Morgan Stanley MUFG Securities Co., Ltd. | Position 249,518 shares | Ratio 0.72% | ▲0.18% | — |
| 2026-09-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 189,118 shares | Ratio 0.54% | ▲0.09% | — |
| 2026-08-31 | Morgan Stanley MUFG Securities Co., Ltd. | Position 137,038 shares | Ratio 0.39% | ▼0.16% | Below 0.5% |
| 2026-08-31 | Citigroup Global Markets Limited | Position 90,323 shares | Ratio 0.26% | ▼1.68% | Below 0.5% |
| 2026-08-31 | Barclays Capital Securities Ltd | Position 450,225 shares | Ratio 1.30% | ▼0.26% | — |
| 2026-08-28 | Citigroup Global Markets Limited | Position 671,097 shares | Ratio 1.94% | ▲0.13% | — |
| 2026-08-27 | Barclays Capital Securities Ltd | Position 540,400 shares | Ratio 1.56% | ▼0.05% | — |
| 2026-08-26 | Morgan Stanley MUFG Securities Co., Ltd. | Position 190,474 shares | Ratio 0.55% | ▲0.09% | — |
| 2026-08-25 | Citigroup Global Markets Limited | Position 625,497 shares | Ratio 1.81% | ▲0.03% | — |
| 2026-08-18 | Barclays Capital Securities Ltd | Position 559,000 shares | Ratio 1.61% | ▲0.08% | — |
| 2026-08-17 | Citigroup Global Markets Limited | Position 615,397 shares | Ratio 1.78% | ▼0.06% | — |
| 2026-08-13 | Citigroup Global Markets Limited | Position 637,697 shares | Ratio 1.84% | ▼0.08% | — |
| 2026-08-12 | Citigroup Global Markets Limited | Position 663,897 shares | Ratio 1.92% | ▲0.03% | — |
| 2026-08-10 | Barclays Capital Securities Ltd | Position 529,000 shares | Ratio 1.53% | ▲0.13% | — |
| 2026-08-10 | Citigroup Global Markets Limited | Position 653,097 shares | Ratio 1.89% | ▲0.59% | — |
| 2026-08-07 | Morgan Stanley MUFG Securities Co., Ltd. | Position 137,693 shares | Ratio 0.39% | ▼0.11% | Below 0.5% |
| 2026-08-06 | Barclays Capital Securities Ltd | Position 486,000 shares | Ratio 1.40% | ▲0.07% | — |
| 2026-08-05 | Citigroup Global Markets Limited | Position 449,097 shares | Ratio 1.30% | ▲0.10% | — |
| 2026-08-04 | Barclays Capital Securities Ltd | Position 462,100 shares | Ratio 1.33% | ▲0.04% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |